相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Design, Synthesis, and Antifungal Evaluation of Cryptolepine Derivatives against Phytopathogenic Fungi
Yong-Jia Chen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)
The harsh microenvironment in early breast cancer selects for a Warburg phenotype
Mehdi Damaghi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunity
Ke Xu et al.
SCIENCE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Non-classical cardenolides from Calotropis gigantea exhibit anticancer effect as HIF-1 inhibitors
Zhiyuan Zheng et al.
BIOORGANIC CHEMISTRY (2021)
Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2)
Andrew D. James et al.
BRITISH JOURNAL OF CANCER (2020)
Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas
Han Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Alkaloids from Cryptolepis sanguinolenta as Potential Inhibitors of SARS-CoV-2 Viral Proteins: An In Silico Study
Lawrence Sheringham Borquaye et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Synthesis of Uscharin Oxime Analogues and Their Biological Evaluation as HIF-1 Inhibitors
Xiaobo Zhou et al.
CHEMISTRYSELECT (2020)
Secretome profiling of heterotypic spheroids suggests a role of fibroblasts in HIF-1 pathway modulation and colorectal cancer photodynamic resistance
Maria Julia Lamberti et al.
CELLULAR ONCOLOGY (2019)
Tumor-associated macrophages: role in cancer development and therapeutic implications
Arash Salmaninejad et al.
CELLULAR ONCOLOGY (2019)
Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis
Meysam Yousefi et al.
CELLULAR ONCOLOGY (2018)
Collagen prolyl 4-hydroxylase 1 is essential for HIF-1α stabilization and TNBC chemoresistance
Gaofeng Xiong et al.
NATURE COMMUNICATIONS (2018)
HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model
Dong Hwan Kim et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Synthesis and evaluation of novel 12-aryl berberine analogues with hypoxia-inducible factor-1 inhibitory activity
Xiaobo Zhou et al.
RSC ADVANCES (2017)
Cardenolides from Calotropis gigantea as potent inhibitors of hypoxia-inducible factor-1 transcriptional activity
Supawadee Parhira et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
Synthesis, analysis and biological evaluation of novel indolquinonecryptolepine analogues as potential anti-tumour agents
A. Le Gresley et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Luana Schito et al.
TRENDS IN CANCER (2016)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells
Juan Ma et al.
ONCOLOGY REPORTS (2014)
2′-Epi-uscharin from the Latex of Calotropis gigantea with HIF-1 Inhibitory Activity
Supawadee Parhira et al.
SCIENTIFIC REPORTS (2014)
Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling
Annika Foehrenbacher et al.
FRONTIERS IN ONCOLOGY (2013)
Cap-Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target
Yan Jia et al.
MEDICINAL RESEARCH REVIEWS (2012)
Control of HIF-1α Expression by eIF2α Phosphorylation-Mediated Translational Repression
Keyi Zhu et al.
CANCER RESEARCH (2009)
Regulation of glucose metabolism-related genes and VEGF by HIF-1α and HIF-1β, but not HIF-2α, in gastric cancer
In-Sung Song et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Anti-inflammatory Properties of Cryptolepine
Olumayokun A. Olajide et al.
PHYTOTHERAPY RESEARCH (2009)
5-N-Methylated Quindoline Derivatives as Telomeric G-Quadruplex Stabilizing Ligands: Effects of 5-N Positive Charge on Quadruplex Binding Affinity and Cell Proliferation
Yu-Jing Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer
Yutaka Yamamoto et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
HIF-1α and CA IX staining in invasive breast carcinomas:: Prognosis and treatment outcome
Cynthia Trastour et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Hypoxia-inducible factor-1α-expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer
Daniele Generali et al.
CLINICAL CANCER RESEARCH (2006)
Hypoxia signalling in cancer and approaches to enforce tumour regression
Jacques Pouyssegur et al.
NATURE (2006)
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
Å Kronblad et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Mechanisms of induction of cell cycle arrest and cell death by cryptolepine in human lung adenocarcinoma A549 cells
HJ Zhu et al.
TOXICOLOGICAL SCIENCES (2006)
Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer:: Retrospective study in a series of 745 patients
JP Dales et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-lot dependent
A Giatromanolaki et al.
CLINICAL CANCER RESEARCH (2004)
Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils -: Cooperation of a MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, mTOR-related THR389 kinase
JA Lehman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α
Y Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Levels of hypoxia-inducible factor-1α independently predict prognosis in patients with lymph node negative breast carcinoma
R Bos et al.
CANCER (2003)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
KL Talks et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
